• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《菊三七致儿童肝窦阻塞综合征 1 例报告》。

Gynura segetum induces hepatic sinusoidal obstruction syndrome in a child: A case report.

机构信息

Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.

Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.

出版信息

Medicine (Baltimore). 2024 Mar 15;103(11):e37341. doi: 10.1097/MD.0000000000037341.

DOI:10.1097/MD.0000000000037341
PMID:38489699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10939675/
Abstract

RATIONALE

Hepatic sinusoidal obstruction syndrome (HSOS), which includes hepatic stasis and portal hypertension, is a rare vascular disorder of the liver. It is often associated with hematopoietic stem cell transplantation. It is also possible to treat this disease using Chinese herbal medicines that contain pyrrolizidine alkaloids (PAs). This disease is extremely rare in children and poses a serious threat to their health. To our knowledge, this is the first case of HSOS in a child with PAs.

PATIENT CONCERNS

We report a 4-year-old boy suffering from abdominal pain, hepatomegaly, massive ascites, elevated liver enzyme level, and severe portal hypertension as a result of the consumption of Gynura segetum (also known as Tusanqi in Chinese, a traditional herbal medicine containing PAs).

DIAGNOSES

The child was finally diagnosed with PA-HSOS based on pathological diagnosis and imaging examination.

INTERVENTION

With active symptomatic and supportive care and sequential anticoagulation therapy, the abdominal distension and liver function improved in the patient.

OUTCOMES

The patient was eventually recovered. The levels of liver enzymes, hemoglobin, and bilirubin were normal, and the international normalized ratio fluctuated between 2.0 and 3.0 during 1-year follow-up after discharge.

LESSONS

This case report emphasizes the prevention of Chinese herb-induced liver injury in children and the importance of active long-term sequential anticoagulant therapy to reduce the progressive damage of PA-HSOS in the liver.

摘要

背景

肝窦阻塞综合征(HSOS)包括肝淤血和门静脉高压,是一种罕见的肝脏血管疾病。它常与造血干细胞移植有关。也可以使用含有吡咯里西啶生物碱(PAs)的中草药来治疗这种疾病。这种疾病在儿童中极为罕见,对其健康构成严重威胁。据我们所知,这是首例儿童 PAs 相关 HSOS 病例。

病例描述

我们报告了一例 4 岁男孩,因食用三叶鬼针草(又称图山齐,一种含有 PAs 的传统草药)而出现腹痛、肝肿大、大量腹水、肝酶水平升高和严重门静脉高压。

诊断

根据病理诊断和影像学检查,患儿最终被诊断为 PAs-HSOS。

干预措施

通过积极的对症支持治疗和序贯抗凝治疗,患者腹胀和肝功能改善。

结果

患儿最终康复。出院后 1 年随访期间,肝酶、血红蛋白和胆红素水平正常,国际标准化比值在 2.0 至 3.0 之间波动。

教训

本病例报告强调了预防儿童中药肝损伤的重要性,以及积极进行长期序贯抗凝治疗以减少 PA-HSOS 在肝脏进行性损害的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/10939675/a6c95dca4a6a/medi-103-e37341-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/10939675/faec6189e904/medi-103-e37341-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/10939675/e01276f8cf10/medi-103-e37341-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/10939675/f5c1a2df5899/medi-103-e37341-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/10939675/a6c95dca4a6a/medi-103-e37341-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/10939675/faec6189e904/medi-103-e37341-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/10939675/e01276f8cf10/medi-103-e37341-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/10939675/f5c1a2df5899/medi-103-e37341-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c7f/10939675/a6c95dca4a6a/medi-103-e37341-g004.jpg

相似文献

1
Gynura segetum induces hepatic sinusoidal obstruction syndrome in a child: A case report.《菊三七致儿童肝窦阻塞综合征 1 例报告》。
Medicine (Baltimore). 2024 Mar 15;103(11):e37341. doi: 10.1097/MD.0000000000037341.
2
Tusanqi and hepatic sinusoidal obstruction syndrome.土三七和肝窦阻塞综合征。
J Dig Dis. 2014 Mar;15(3):105-7. doi: 10.1111/1751-2980.12112.
3
Hepatic sinusoidal obstruction syndrome caused by the ingestion of in a patient with alcoholic cirrhosis: a case report.酒精性肝硬化患者因摄入[具体物质未给出]导致肝窦阻塞综合征:一例报告。
J Int Med Res. 2021 Apr;49(4):300060520980649. doi: 10.1177/0300060520980649.
4
Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.与食用菊三七相关的肝窦阻塞综合征。
J Hepatol. 2011 Apr;54(4):666-73. doi: 10.1016/j.jhep.2010.07.031. Epub 2010 Sep 22.
5
Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver Disease with High Mortality and Misdiagnosis Rate.菊三七相关肝窦阻塞综合征:一种高死亡率和误诊率的肝脏疾病。
Curr Pharm Des. 2019;25(35):3762-3768. doi: 10.2174/1381612825666191007162024.
6
Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.吡咯里西啶生物碱诱导的肝窦阻塞综合征的 CT 增强扫描诊断性能。
Sci Rep. 2016 Nov 29;6:37998. doi: 10.1038/srep37998.
7
Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.吡咯里西啶生物碱诱导的肝窦阻塞综合征临床管理专家共识。
J Gastroenterol Hepatol. 2019 Apr;34(4):634-642. doi: 10.1111/jgh.14612. Epub 2019 Feb 21.
8
Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.吡咯里西啶生物碱所致肝窦阻塞综合征的明确诊断。
J Dig Dis. 2012 Jan;13(1):33-9. doi: 10.1111/j.1751-2980.2011.00552.x.
9
Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.吡咯里西啶生物碱诱导的肝窦阻塞综合征:发病机制、临床表现、诊断、治疗和结局。
World J Gastroenterol. 2019 Jul 28;25(28):3753-3763. doi: 10.3748/wjg.v25.i28.3753.
10
Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors.莪术根茎含吡咯里西啶生物碱,通过上调纤维化相关因子诱导小鼠肝窦阻塞综合征。
Acta Pharmacol Sin. 2019 Jun;40(6):781-789. doi: 10.1038/s41401-018-0155-y. Epub 2018 Oct 26.

本文引用的文献

1
Prognostic risk factors for patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids.吡咯里西啶生物碱所致肝窦阻塞综合征患者的预后危险因素。
Medicine (Baltimore). 2023 Aug 11;102(32):e34698. doi: 10.1097/MD.0000000000034698.
2
Clinical Features and CT Imaging Analysis of Hepatic Sinuscase-Syndrome and Budd-Chiari Syndrome.肝窦综合征与布加综合征的临床特征及CT影像分析
Int J Gen Med. 2022 Mar 2;15:2389-2396. doi: 10.2147/IJGM.S348176. eCollection 2022.
3
Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
吡咯里西啶生物碱诱导的肝窦阻塞综合征患者经颈静脉肝内门体分流术的时机和疗效。
Sci Rep. 2021 Nov 5;11(1):21743. doi: 10.1038/s41598-021-01201-w.
4
Hepatic sinusoidal obstruction syndrome after oral intake of Gynura segetum.口服紫背天葵后发生的肝窦阻塞综合征
Asian J Surg. 2021 Jul;44(7):991-993. doi: 10.1016/j.asjsur.2021.04.015. Epub 2021 Apr 26.
5
Hepatic sinusoidal obstruction syndrome caused by the ingestion of in a patient with alcoholic cirrhosis: a case report.酒精性肝硬化患者因摄入[具体物质未给出]导致肝窦阻塞综合征:一例报告。
J Int Med Res. 2021 Apr;49(4):300060520980649. doi: 10.1177/0300060520980649.
6
Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.经颈静脉肝内门体分流术治疗与紫背天葵食用相关的肝窦阻塞综合征
BMC Gastroenterol. 2021 Jan 10;21(1):26. doi: 10.1186/s12876-021-01599-7.
7
Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China.土木香(旋覆花):中国吡咯里西啶生物碱肝损伤的罪魁祸首。
Acta Pharmacol Sin. 2021 Aug;42(8):1212-1222. doi: 10.1038/s41401-020-00553-9. Epub 2020 Nov 5.
8
Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports.低分子量肝素治疗吡咯里西啶生物碱所致肝窦阻塞综合征:5例报告
J Int Med Res. 2020 Sep;48(9):300060520961916. doi: 10.1177/0300060520961916.
9
Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver Disease with High Mortality and Misdiagnosis Rate.菊三七相关肝窦阻塞综合征:一种高死亡率和误诊率的肝脏疾病。
Curr Pharm Des. 2019;25(35):3762-3768. doi: 10.2174/1381612825666191007162024.
10
Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.吡咯里西啶生物碱诱导的肝窦阻塞综合征:发病机制、临床表现、诊断、治疗和结局。
World J Gastroenterol. 2019 Jul 28;25(28):3753-3763. doi: 10.3748/wjg.v25.i28.3753.